http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2247460-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c266d15793ee656e0b009f4f0f9ce8b0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49
filingDate 1997-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03dd0dca173794d70b456af7414b5452
publicationDate 1997-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2247460-A1
titleOfInvention Recombinant tissue plasminogen activator (rtpa) for preventing secondary cataracts following cataract operations
abstract The present invention relates to the use of RTPA to prevent the post-operative proliferation of lens tissues, known as secondary cataracts, on the posterior sheath well (fibrosis) after extracapsular cataract extraction.
priorityDate 1996-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25692
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100128998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722

Total number of triples: 22.